Susquehanna Fundamental Investments, LLC Stoke Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $2.14 Trillion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$30.53 - $41.09 $234,531 - $315,653
-7,682 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$36.08 - $69.81 $47,192 - $91,311
-1,308 Reduced 14.55%
7,682 $298,000
Q4 2020

Feb 16, 2021
BUY
$33.62 - $61.93 $302,243 - $556,750
8,990 New
8,990 $557,000

Others Institutions Holding STOK

# of Institutions
111
Shares Held
50M
Call Options Held
63K
Put Options Held
111K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $506M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email